Ebola Vaccine Breakthrough: Oxford University has begun the first human Phase I trial of a Bundibugyo ebolavirus vaccine (ChAdOx1 BDBV), recruiting 50 healthy adults in the UK and using stockpiled doses to speed future deployment; researchers say preparations are also underway for related studies in Uganda. DRC Outbreak Update: The Bundibugyo outbreak in the Democratic Republic of Congo continues to expand across multiple provinces, with health authorities reporting rising confirmed cases and deaths, while regional preparedness efforts intensify. Uganda Trial Logistics: Uganda-linked partners are preparing for possible vaccine studies, including work with UVRI and other research units, as the world races to find targeted tools for this rare Ebola strain. Health System Accountability: Makerere’s CAGE-TB smartphone cough-sound TB project faces scrutiny after audit findings flagged overstated spending, unbudgeted costs and poor use of available funds. Care and Ethics in Hospitals: Mbarara Regional Referral Hospital sparked debate after announcing the death of its “longest staying ICU patient,” raising questions about how health facilities communicate sensitive cases. Public Health Practice: Soroti city health workers were warned not to misuse government motorcycles meant for immunisation and outreach. Access to Care & Travel: The US suspended visa operations for Uganda and nearby Ebola-affected countries, citing public health safety.